// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Incidence and Outcomes of Out-of-hospital Maternal Cardiac Arrest and Compliance with Resuscitation Guidelines

Sheldon Cheskes - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Spatiotemporal Stability of Public Cardiac Arrests

Steven C. Brooks - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Spatiotemporal AED Location Optimization

Christopher L. f. Sun - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Thoracic Aortic Dilation in Patients with Bicuspid Aortic Valves is Marked by Accelerated Vascular Smooth Muscle Cell Aging

Hao Yin - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Bicuspid aortic valve

N/A

Epinephrine in Cardiac Arrest: A Randomized, Multicenter, Double-blinded, Placebo-controlled Experimental Trial

Matthew L Sundermann - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Epinephrine

Magnetic Resonance Imaging Characterization of Peripheral Arterial Chronic Total Occlusions With MicroCT and Histologic Validation

Garry Liu - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Chronic total occlusion

N/A

Paraoxonase 1 (PON1) Promotes the Cholesterol Efflux and Regulates the Reverse Cholesterol Transport (RCT)

Hicham Berrougui - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

GW9662

Automating Cardiopulmonary Resuscitation Quality Data Abstraction for Entire Episodes of Cardiac Arrest Resuscitation

Anuar Turgulov - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Lymphatic derived HDL Is an Effective Donor for the Trans-Intestinal Cholesterol Efflux Pathway That Is Impaired During Insulin Resistance

Faye Borthwick - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

What is the Resilience of Out-of-hospital Cardiac Arrest Patients Who Do Not Receive Bystander Resuscitation?

Frank Xavier Scheuermeyer - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Liver X Receptors (LXR) Modulate the Negative Effects on Endothelial Progenitors Cells after Feeding a High Cholesterol Diet

Carolyn L Cummins - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Effects of Statins on Adiponectin Receptor Expression on Circulating Monocytes in Hypertensive and Dyslipidemic Subjects

Huaien Zheng - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Dyslipidemia

N/A

Predictors of Long-term Mortality for Survivors of Out-of-hospital Cardiac Arrest

Laurie J Morrison - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Myocardial infarction

N/A

9p21.3 Coronary Artery Disease Risk Variants Disrupt Tead Transcription Factor Binding and Tead-dependent Tgf? Induction of P16 Expression

Darlene Antoine - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

A North American Survey of Public Opinion on the Acceptability of Crowdsourcing Basic Life Support for Out-of-hospital Cardiac Arrest

Steven Brooks - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Are Prolonged Resuscitation Efforts Worthwhile? Patient Outcomes by Time to Restoration of Spontaneous Circulation in Out-of-hospital Cardiac Arrest Patients

Monique Anderson - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Use of Goal Directed Transesophageal Echocardiography in the Arresting Patient

Robert Arntfield - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Ultrafast Cooling with Total Liquid Ventilation Attenuates Multi-organ Failure and Sepsis-like Response After Experimental Shock Induced by Aortic Cross Clamping

Matthias Kohlhauer - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemia-reperfusion injury

Norepinephrine bitartrate

Murine Cre/flox Studies Indicate Yolk Sac Derived Macrophages Are the Cellular Source of FXIIIA

Kathryn J Griffin - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Decreased Circulating and Neutrophil Mediated Vegf Release in Stable Long-term Cardiac Transplant Recipients

Damien Vitiello - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac allograft vasculopathy

Interleukin

Copyright © 2026. QuantiNova All rights reserved